Clinical Trials

310 enrolled

Lymphoid

Burkitt Lymphoma

NCT06671912 2026-03-04

LoTam

1,156 enrolled

Breast Carcinoma In Situ

NCT05378763 2026-02-18

PINNACLE

268 enrolled

Thoracic

NSCLC

NCT05351294 2026-01-07

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

156 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06940570 2025-10-23

MATCH

Classical hematologyOtherOther hematologic neoplasm

60 enrolled

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT04973930 2025-05-13

IPT

20 enrolled

Breast Neoplasms, Depressive Disorder, Major

NCT02037529 2024-08-20

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

201 enrolled 19 charts

Breast Neoplasms

NCT04684628 2024-05-02

68Ga-PSMA PET/CT in Prostate Cancer

500 enrolled

Genitourinary

Prostatic Neoplasms

NCT02546102 2024-04-03

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

234 enrolled

CNS

Glioblastoma

NCT05503108 2023-11-22

DIRECT-2

10 enrolled

Fasting Mimicking Diet

NCT03002103 2023-04-26

A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer

420 enrolled

Triple Negative Breast Neoplasms

NCT02121405 2022-05-11

PSSR

350 enrolled

Radiation Injuries, Colorectal Neoplasms

NCT04001010 2021-02-05

SERENITY

334 enrolled

Cachexia, Neoplasms

NCT02091661 2020-03-25

Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer

500 enrolled

Genitourinary

Prostatic Neoplasms

NCT03990974 2020-03-25

HCC

458 enrolled

Carcinoma, Hepatocellular

NCT03777579 2019-08-08

A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC

375 enrolled

Triple Negative Breast Neoplasms

NCT01218490 2019-05-16

CARACO

450 enrolled

Gynecologic

Ovarian Neoplasms

NCT01755325 2018-04-25

Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+

MyeloidOther hematologic neoplasm

680 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01356329 2016-05-13

Lovenox

150 enrolled

Malignant Female Reproductive System Neoplasm

NCT00892346 2016-05-10

Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma

80 enrolled

Plasma cell

Multiple Myeloma

NCT00324831 2013-12-18

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

480 enrolled

Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00002696 2013-08-02

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

Breast Neoplasms

NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

LymphoidOther hematologic neoplasm

100 enrolled

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01330823 2011-04-07

CARPAN

72 enrolled

Fatigue, Pancreatic Neoplasms, Malnutrition

NCT00540280 2011-03-08

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

10 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00865488 2009-12-23

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

80 enrolled

Gynecologic

Tissue Adhesions, Endometriosis, Ovarian Cysts

NCT00921635 2009-06-19

HOSTT

Classical hematologyGynecologic

2 enrolled

Anemia, Uterine Cervical Neoplasms

NCT00316745 2007-11-01

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

200 enrolled

Colorectal Neoplasms

NCT00211952 2005-09-21

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients